Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hepatoblastoma × Filgrastim × Clear all

Sponsor

Conditions

Lymphoma 50 Multiple Myeloma 47 Leukemia 39 Leukemia, Myeloid, Acute 38 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Lymphoma, Non-Hodgkin 34 Myelodysplastic Syndromes 31 Hodgkin Disease 31 Lymphoma, Large B-Cell, Diffuse 26 Lymphoma, Mantle-Cell 25 Leukemia, Lymphocytic, Chronic, B-Cell 23 Lymphoma, Follicular 22 Breast Neoplasms 20 Burkitt Lymphoma 18 Lymphoma, B-Cell, Marginal Zone 16 Lymphoma, Large-Cell, Immunoblastic 14 Congenital Abnormalities 14 Recurrence 12 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11 Sarcoma 10 Neoplasms, Plasma Cell 10 Leukemia, Myelomonocytic, Juvenile 9 Leukemia, Biphenotypic, Acute 9 Leukemia, Myelomonocytic, Chronic 8 Hematologic Neoplasms 8 Blast Crisis 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Neuroblastoma 7 Myeloproliferative Disorders 7 Leukemia, Myeloid, Accelerated Phase 7

Interventions

X-Rays 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Nuclear Medicine Department, Hospital 3 Biopsy 2 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 palbociclib 1 olaparib 1 larotrectinib 1 erdafitinib 1 cixutumumab 1 Vemurafenib 1 Pharmacogenomic Variants 1 MLN 8237 1 LY3023414 1 Cyproheptadine 1 Arsenic Trioxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡